Evolution of SARS-CoV-2 IgG Seroprevalence in Children and Factors Associated with Seroconversion: Results from a Multiple Time-Points Study in Friuli-Venezia Giulia Region, Italy.
COVID-19
IgG antibodies
Italy
children
seroprevalence
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
12 Feb 2022
12 Feb 2022
Historique:
received:
17
12
2021
revised:
01
02
2022
accepted:
08
02
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
26
2
2022
Statut:
epublish
Résumé
Data on the effective burden of the SARS-CoV-2 pandemic in the pediatric population are limited. We aimed at assessing the prevalence of SARS-CoV-2 IgG antibodies in children at three subsequent time-points. The study was conducted between January 2021 and July 2021 among children referring to the Research Institute for Maternal and Child Health "Burlo Garofolo" in Trieste, a referral regional hospital in Friuli Venezia Giulia, Italy. A multivariate analysis was conducted to assess factors independently associated with seroconversion. A total of 594 children were included. Anti-SARS-CoV-2 trimeric Spike protein IgG antibodies were found in 32 (15.4%) children tested in April-May and in 20 (11.8%) in June-July 2021, compared with 24 (11.1%) of those tested in January-February 2021 (
Identifiants
pubmed: 35204966
pii: children9020246
doi: 10.3390/children9020246
pmc: PMC8870333
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
JAMA Netw Open. 2021 Mar 1;4(3):e214302
pubmed: 33749770
J Infect. 2020 Dec;81(6):e10-e12
pubmed: 32961253
Lancet Public Health. 2021 Jun;6(6):e408-e415
pubmed: 33838700
J Infect. 2021 Nov 30;:
pubmed: 34861351
BMJ. 2021 Mar 17;372:n616
pubmed: 33731327
N Engl J Med. 2022 Jan 6;386(1):35-46
pubmed: 34752019
J Clin Med. 2020 Nov 05;9(11):
pubmed: 33167563
EBioMedicine. 2021 Oct;72:103615
pubmed: 34649078
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
Pediatr Allergy Immunol. 2021 May;32(4):762-770
pubmed: 33512035
Int J Environ Res Public Health. 2021 Feb 04;18(4):
pubmed: 33557402
JAMA Netw Open. 2021 Apr 1;4(4):e217097
pubmed: 33890990
Arch Dis Child. 2021 Jul;106(7):680-686
pubmed: 33172887
Pediatr Pulmonol. 2021 Jun;56(6):1374-1377
pubmed: 33470561
Nat Immunol. 2021 Jan;22(1):25-31
pubmed: 33154590
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Acta Clin Belg. 2021 Nov 18;:1-9
pubmed: 34789077
Pediatr Investig. 2020 Dec 28;4(4):236-241
pubmed: 33376950
Ital J Pediatr. 2021 Jun 5;47(1):131
pubmed: 34090486
Cell Rep. 2022 Feb 8;38(6):110345
pubmed: 35090598
Epidemiol Prev. 2020 Jul-Aug;44(4):304-307
pubmed: 32921037
Clin Infect Dis. 2021 Apr 8;72(7):e192-e195
pubmed: 33161427
Future Sci OA. 2021 Jan 12;7(4):FSO673
pubmed: 33815819
Int J Infect Dis. 2021 Jun;107:116-120
pubmed: 33892190
Clin Microbiol Infect. 2021 Mar;27(3):331-340
pubmed: 33228974
Lancet Infect Dis. 2021 May;21(5):600-601
pubmed: 33539733